Developing bioactive composite materials for tissue replacement.
By Min Wang. Biomaterials, 2003
734 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Surgery
View Paper: https://www.semanticscholar.org/paper/e6c08688370d82086552c1c6a0d9b2084c924919
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
In Surgery
Citations in the corpus
- Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. (2006, background): “However, their clinical applications have been limited because of their brittleness, difficulty of shaping [9], and an extremely slow degradation rate in the case of HA [10].”
- Hydroxyapatite nanocomposites: Synthesis, sintering and mechanical properties (2013, background): “TCP is fragile bioceramic and consequently cannot be used on their own as major load-bearing implants in the human body[14].”
- Silk fibroin biomaterials for tissue regenerations. (2013, background): “Poor compatibility between components results in inhomogeneous mixtures, phase separation and adverse tissue reactions [103].”
- Chitosan Composites for Bone Tissue Engineering—An Overview (2010, background): “Chitosan (CTS) and hydroxyapatite (HAp) are among the best bioactive biomaterials in bone tissue engineering and renowned for their excellent biocompatibility with the human body environment [4].”